epirubicin has been researched along with as 1411 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abnous, K; Alibolandi, M; Bahreyni, A; Hassanzadeh, P; Ramezani, M; Taghdisi, SM | 1 |
| Abnous, K; Alibolandi, M; Moradi, E; Ramezani, M; Taghdisi, SM; Zavvar, T | 1 |
| Abnous, K; Alibolandi, M; Khademi, Z; Mirzaei, S; Ramezani, M; Taghdisi, SM; Zolfaghari, R | 1 |
3 other study(ies) available for epirubicin and as 1411
| Article | Year |
|---|---|
High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
Topics: Aptamers, Nucleotide; Copper; Epirubicin; Fluorescent Dyes; Humans; Limit of Detection; MCF-7 Cells; Oligodeoxyribonucleotides; Proof of Concept Study | 2019 |
Targeted delivery of epirubicin to breast cancer cells using poly-aptamer DNA nanocarriers prepared by the RCA method with multiple repeats of aptamers of FOXM1 and AS1411.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; DNA; Drug Delivery Systems; Epirubicin; Mice; Nanoparticles; Neoplasms | 2023 |
Dual-targeted delivery system using hollow silica nanoparticles with H
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Drug Delivery Systems; Epirubicin; Female; Humans; Hyaluronic Acid; MCF-7 Cells; Mice; Nanoparticles; Silicon Dioxide | 2023 |